Kalaris Therapeutics (KLRS)
Nasdaq • KLRS • US4829291065
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 27, 2026, ORTEX estimated 5.3% of free float sold short, 3.6 days to cover, cost to borrow 1.56%. Sign up for live short interest data.
Market Cap
45.8m USD | # 9395 in US
Volume
71.02k shares | 210.32k USD
Shares Outstanding
23.8m
Free Float Shares
24.76% | 5.9m
